A comprehensive, single-center, 20-year retrospective analysis conducted in Russia and published in Children has provided key ...
Takeda Pharmaceutical Company Limited announced detailed results from the pivotal Phase 2/3 IgGNITE clinical trial (TAK-881-3001) evaluating investigational TAK-881 [Immune Globulin Subcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results